Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization growth accelerates
Q2 FY2026 depreciation & amortization of $3.93M rose 182.3% year over year, ahead of the +175.4% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 5.9% from the prior quarter. Over 3 fiscal years it compounded at +103.8% a year.
Context
- Depreciation & amortization amounted to 0.8% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +182.3% holds above the trailing-twelve-month pace of +175.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 6.83M USD
- Year-over-year change
- +116.5%
- 3-year CAGR
- +103.8%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.83M | +116.5% |
| FY2024 | 2024-12-31 | 3.15M | +77.1% |
| FY2023 | 2023-12-31 | 1.78M | +120.7% |
| FY2022 | 2022-12-31 | 807K | — |
Depreciation & Amortization vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's LTM Jun 2026 depreciation & amortization of $11.95M is the smallest of the 7 companies compared; the peer median is $1.13B.
- Its year-over-year change of +175.4% is the highest of 7, against a peer median of +9.0%.
- Depreciation & amortization amounts to 1.0% of revenue for ALAB, versus a peer median of 8.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.26B | +20.6% | +26.9% | 10.9% | |
| LTM Aug 2026 | $1.97B | -2.6% | -4.5% | 14.2% | |
| LTM Aug 2026 | $1.26B | -4.8% | -2.5% | 13.3% | |
| LTM Jun 2026 | $1B | +21.3% | +2.2% | 5.2% | |
| LTM Aug 2026 | $49.78M | +114.9% | +53.8% | 3.1% | |
| LTM Sep 2026 | $37.77M | -3.8% | -15.1% | 5.7% | |
| LTM Jun 2026 | $11.95M | +175.4% | +103.8% | 1.0% | |
| Peer median (excluding ALAB) | $1.13B | +9.0% | -0.1% | 8.3% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Net Income | (58.35M) | (26.26M) | (83.42M) | 219.13M |
| Depreciation & Amortization | 807K | 1.78M | 3.15M | 6.83M |
| Deferred Income Tax | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 30.24M | 10.68M | 234.59M | 160.03M |
| Change in Working Capital | (9.97M) | (9.68M) | (13.3M) | (65.96M) |
| Accounts Receivables | (6.04M) | 2.39M | (30.48M) | (44.34M) |
| Inventory | (19.36M) | (5.56M) | (19.29M) | (12.95M) |
| Accounts Payables | 2.13M | (4.26M) | 20.89M | 14.19M |
| Other Working Capital | 13.3M | (2.23M) | 15.59M | (22.87M) |
| Other Non-Cash Items | 1.38M | 10.76M | (4.35M) | (726K) |
| Operating Cash Flow | (35.9M) | (12.72M) | 136.68M | 319.31M |
| Capital Expenditures | (3.87M) | (2.76M) | (34.25M) | (37.54M) |
| Acquisitions (Net) | 0 | 0 | 0 | (28.79M) |
| Purchases of Investments | (88.71M) | (126.23M) | (930.58M) | (857.75M) |
| Sales of Investments | 2M | 111.21M | 208.67M | 683.11M |
| Other Investing Activities | 0 | 0 | (1.41M) | (500K) |
| Investing Cash Flow | (90.59M) | (17.77M) | (757.57M) | (241.47M) |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 672.2M | 9.8M |
| Common Stock Repurchased | (313K) | (210K) | (1.07M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.12M | (292K) | (15.29M) | 0 |
| Financing Cash Flow | 151.67M | (502K) | 655.84M | 9.8M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 |
| Net Change in Cash | 25.18M | (30.99M) | 34.95M | 87.64M |
| Free Cash Flow | (39.77M) | (15.48M) | 102.43M | 281.76M |
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.